Oct 22 | Apr 22 | Oct 21 | Apr 21 | Oct 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 374.90M | £ 273.70M | £ 351.80M | £ 229.70M | £ 240.20M |
Total Assets | £ 1.58B | £ 1.64B | £ 1.61B | £ 1.47B | £ 1.47B |
Total Debt | £ 101.00M | £ 102.00M | £ 102.50M | £ 103.30M | £ 104.20M |
Net Debt | £ -273.90M | £ -171.70M | £ -249.30M | £ -126.40M | £ -136.00M |
Total Liabilities | £ 696.10M | £ 793.70M | £ 706.80M | £ 601.70M | £ 641.90M |
Stockholders Equity | £ 883.10M | £ 846.30M | £ 901.60M | £ 869.10M | £ 825.30M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |